Rolziracetam

Rolziracetam
Clinical data
Other names	2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione
Routes of; administration	Oral
Legal status
Legal status	Unscheduled (US);
Identifiers
	IUPAC name dihydro-1H-pyrrolizine-3,5(2H,6H)-dione;
CAS Number	18356-28-0;
PubChem CID	71893;
CompTox Dashboard (EPA)	DTXSID80171444 ;
Chemical and physical data
Formula	C7H9N2O2
Molar mass	139.152 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CC(=O)N2C1CCC2=O;

Rolziracetam is a nootropic drug of the racetam family.

Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. ^[1]

References

^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

This article about an organic compound is a stub. You can help Wikipedia by expanding it.

[1] Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.

[1]

See also

References